SFStanislav Fedorov

Stanislav Fedorov

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Stanislav Fedorov has a total of 34 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Cross-Species Triage of SERT-Oriented Polyheteroaryl Candidates Prioritizes AD20/UtIA-0108 as an Early Neuroactive Candidate

    by Maria V. Komelkova, Stanislav A. Fedorov, Veronika A. Isaeva, Irina A. Utepova, Yulia D. Grygoreva, Inessa Yu Bahareva, Vitalii S. Moskaliuk, Elena M. Kondaurova, Alexandr V. Zhdanov, Pavel O. Platkovskii, et al.

    Depression and stress-related disorders remain important targets for the development of new neuroactive compounds. We evaluated three imidazo[1,2-a]pyridine–[1,2,5]oxadiazolo[3,4-b]pyrazine derivatives, selected by a SERT-oriented computational screen, using chemical characterization, zebrafish embryo toxicity, larval and adult zebrafish behavioural assays, mouse behavioural HPLC, and qPCR experiments. AD19/UtIA-0167 had the highest computational consensus but showed greater embryo toxicity and no consistent advantage in adult zebrafish. AD20/UtIA-0108 showed a distinct larval locomotor profile, increased middle-zone occupancy after chronic exposure in stressed adult zebrafish, and was therefore examined in mice. Chronic AD20 increased latency to enter the dark compartment; whereas, time in the light compartment, open-field measures and forced-swim immobility were unchanged. HPLC and qPCR changes were region-specific and did not demonstrate direct SERT engagement. AD20 should therefore be regarded as an early neuroactive candidate from a SERT-oriented screen, not as a confirmed SERT inhibitor or antidepressant. Interpretation across species is limited by the duplicated zebrafish serotonin-transporter system, waterborne exposure and the limited scope of the mouse behavioural effect. Direct transporter assays, pharmacokinetic studies and independent behavioural replication are required.

  • Open Access

    Zebrafish as a Model Organism for Post-Traumatic Stress Disorder: Insights into Stress Mechanisms and Behavioral Assays

    by Alexey Sarapultsev, Maria Komelkova, Oleg Lookin, Sergey Khatsko, Alexander Zhdanov, Stanislav Fedorov, Evgenii Gusev, Alexander Trofimov, Tursonjan Tokay, Desheng Hu

    The zebrafish (Danio rerio) has emerged as a powerful model organism for investigating the mechanisms of post-traumatic stress disorder (PTSD), offering unique advantages in translational relevance, genetic trackability, and cost-effectiveness. As a logical continuation of our recent systematic review, this manuscript critically examines the spectrum of experimental strategies used to model PTSD in zebrafish, with a focus on the comparative efficacy and validity of acute, chronic, and complex stress paradigms. Among these, 14–15-day chronic unpredictable stress (CUS/UCS) protocols are identified as the gold standard, reliably inducing core PTSD-like phenotypes—such as anxiety-like behavior, cortisol dysregulation, and neuroinflammatory gene activation. We discuss the influence of environmental, developmental, and genetic factors on stress responses, and highlight the importance of standardized behavioral and molecular endpoints for model validation. While alternative paradigms—including acute, social, pharmacological, and predator-based models—offer mechanistic insights, their translational relevance remains limited without further refinement. We conclude by outlining future directions for zebrafish-based PTSD research, emphasizing the need for protocol harmonization, integration of multi-modal readouts, and exploration of individual variability to enhance the translational value of this model system.


  • NEURAL NETWORK MODELING OF MULTI-TARGET SEROTONERGIC MECHANISM OF CELLULAR STRESS

    by P.M. Vassiliev, A.P. Sarapultsev, M.V. Komelkova, M.A. Perfilev, A.N. Kochetkov, G.P. Sarapultsev, S.A. Fedorov, P.O. Platkovski, I.A. Utepova, S.L. Deev

    Aim. Construction of a neural network multi-target regression model of the dependence of the SERT affinity of chemical compounds on the energies of their docking into relevant biotargets, sensitivity analysis of the resulting model and identification of key biotargets that most significantly affect the affinity of compounds to the serotonin transporter. Materials and Methods. Data on 2D structure and SERT inhibitory activity of 3436 known compounds and drugs; 478 3D models of human target proteins relevant to SERT inhibitory activity; 10 original and licensed computer programs. The following were performed: construction of optimized 3D models of SERT inhibitory compounds and drugs; identification of biotargets relevant to SERT inhibitory activity; finding binding sites and valid 3D models of these biotargets; ensemble docking of known SERT inhibitors to relevant biotargets, calculation of minimum docking energies, formation of a training set; training and testing of regression neural networks, selection of the best neural network; sensitivity analysis of the neural network multi-target model, identification of key biotargets that significantly affect SERT affinity. Results. 21 biotargets relevant to SERT inhibitory activity were identified, 25 binding sites were revealed for them, 68 valid 3D models were found. Ensemble docking of known SERT inhibitors into relevant biotargets was performed, a training set was formed. 7500 neural networks were trained, a regression neural network model of the dependence of SERT affinity of compounds on their affinity to 24 sites of 20 relevant biotargets was built, having a correlation coefficient RTotal=0.885 and statistical significance p<5·10ˉ⁷. A sensitivity analysis of this model was performed, 12 key biotargets were identified that most significantly affect SERT affinity. Conclusions. Using artificial intelligence methods, 12 key biotargets were found that most significantly affect the affinity to SERT, of which six targets are characterized by a positive effect (ADRA1A, AMPA, DRD1, GAT1, HTR2A Alo, HTR3A) and six targets are characterized by a negative effect (HTR2C, JAK2, MAPK11, NMDA Block, ROCK2, SLC18A2). These biotargets reflect the multitarget mechanism of serotonergic regulation of cellular stress in inflammation and various functional disorders.


  • Open Access

    Hexobarbital Sleep Test for Predicting the Susceptibility or Resistance to Experimental Posttraumatic Stress Disorder

    by Maria Komelkova, Eugenia Manukhina, H. Fred Downey, Alexey Sarapultsev, Olga Cherkasova, Viacheslav Kotomtsev, Pavel Platkovskiy, Stanislav Fedorov, Petr Sarapultsev, Olga Tseilikman, et al.

    Hexobarbital sleep test (HST) was performed in male Wistar rats (hexobarbital 60 mg/kg, i.p.) 30 days prior to stress exposure. Based on the duration of hexobarbital-induced sleep, rats were divided into two groups, animals with high intensity (fast metabolizers (FM), sleep duration <15 min) or low intensity of hexobarbital metabolism (slow metabolizers (SM), sleep duration ≥15 min). The SM and FM groups were then divided into two subgroups: unstressed and stressed groups. The stressed subgroups were exposed to predator scent stress for 10 days followed by 15 days of rest. SM and FM rats from the unstressed group exhibited different behavioral and endocrinological patterns. SM showed greater anxiety and higher corticosterone levels. In stressed animals, anxiety-like posttraumatic stress disorder (PTSD) behavior was aggravated only in SM. Corticosterone levels in the stressed FM, PTSD-resistant rats, were lower than in unstressed SM. Thus, HST was able to predict the susceptibility or resistance to experimental PTSD, which was consistent with the changes in glucocorticoid metabolism.